OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy
Shuai Ding, Jinfeng Liu, Xin Han, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16325-16325
Open Access | Times Cited: 8

Showing 8 citing articles:

CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review
Emir Begagić, Hakija Bečulić, Nermin Đuzić, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 238-238
Open Access | Times Cited: 14

The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9

Potential therapeutic strategy for cancer: Multi-dimensional cross-talk between circRNAs and parental genes
Xiaoyu Sun, Xinyi Zhao, Yan Xu, et al.
Cancer Letters (2024) Vol. 588, pp. 216794-216794
Closed Access | Times Cited: 5

Gene Editing in ErbB/HER Family-Mediated Cancer Immunology
Ling Yin
IntechOpen eBooks (2025)
Closed Access

Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells
Amalia Kotsifaki, Sousanna Maroulaki, Athanasios Armakolas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4832-4832
Open Access | Times Cited: 4

Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment
J. P. Jose Merlin, Heidi Abrahamse
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117516-117516
Open Access | Times Cited: 4

The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 2

Current progress in CRISPR–Cas systems for cancer
Hunaiza Fatima, Hajra Ali Raja, Rabia Amir, et al.
Progress in molecular biology and translational science (2024), pp. 211-229
Closed Access | Times Cited: 1

Page 1

Scroll to top